Singapore markets closed
Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) Bitcoin USD
68,066.66 +906.52 (+1.35%) CMC Crypto 200
1,378.40 +47.79 (+3.59%)
Adaptimmune Therapeutics plc (ADAP)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.3000 |
| Open | 1.3000 |
| Bid | 1.3700 x 1000 |
| Ask | 1.4000 x 1000 |
| Day's range | 1.2950 - 1.4200 |
| 52-week range | 0.4200 - 2.0500 |
| Volume | |
| Avg. volume | 1,661,530 |
| Market cap | 355.231M |
| Beta (5Y monthly) | 2.30 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.7300 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 2.08 |
Insider MonkeyWhy Are Hedge Funds Bullish on Adaptimmune Therapeutics plc (ADAP) Now?
We recently compiled a list of the 10 Best One-Dollar Stocks To Buy Now. In this article, we are going to take a look at where Adaptimmune Therapeutics plc (NASDAQ:ADAP) stands against the other one-dollar stocks. The upward trend in the stock market has resumed, supported by strong first-quarter and second-quarter results that have relieved […]
ZacksAdaptimmune (ADAP) Down on End of Collaboration With Roche
Adaptimmune's (ADAP) shares plummet as the company;s collaboration to develop and commercialize allogeneic cell therapies with Roche gets terminated.
Simply Wall St.Adaptimmune Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Adaptimmune Therapeutics ( NASDAQ:ADAP ) Full Year 2023 Results Key Financial Results Revenue: US$60.3m (up 122% from...
© 2024 Yahoo. All rights reserved.